Trials / Completed
CompletedNCT00806494
UK Study Assessing Flexible Dose Fesoterodine in Adults
A 12 Week, Multi-centre, Open Label Study To Evaluate The Efficacy, Tolerability And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 331 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effects of fesoterodine when used in a flexible dose manner
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fesoterodine | Fesoterodine 4mg for 4 weeks, escalating to fesoterodine 8mg if tolerated |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2008-12-10
- Last updated
- 2011-01-26
- Results posted
- 2011-01-26
Locations
39 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00806494. Inclusion in this directory is not an endorsement.